Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,400
Closed -$328K 144
2024
Q3
$328K Hold
3,400
0.21% 82
2024
Q2
$312K Hold
3,400
0.2% 81
2024
Q1
$313K Hold
3,400
0.22% 80
2023
Q4
$323K Hold
3,400
0.27% 77
2023
Q3
$323K Hold
3,400
0.27% 77
2023
Q2
$311K Hold
3,400
0.27% 85
2023
Q1
$250K Buy
3,400
+900
+36% +$77.9K 0.26% 83
2022
Q4
$209K Buy
2,500
+450
+22% +$40.6K 0.3% 70
2022
Q3
$198K Hold
2,050
0.34% 60
2022
Q2
$215K Hold
2,050
0.33% 60
2022
Q1
$353K Buy
+2,050
New +$306K 0.4% 57

Other funds holding AMED

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s AMED Position: Q4 2024 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold out of Amedisys (AMED) in Q4 2024, closing a stake of 3,400 shares — an estimated $328K sold.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in AMED in Q1 2022 and held it in 11 quarters. The position peaked at $353K in Q1 2022. 291 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 3,400 Amedisys shares in Q4 2024, an estimated $328K.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Amedisys in Q1 2022 and held it in 11 quarters.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Amedisys position peaked at $353K in Q1 2022.
  • 291 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q4 2024, filed 5 Feb 2025.